Abstract
Background
Endophyte bestows beneficial aspects to its inhabiting host, along with a contribution to diverse structural attributes with biological potential. In this regard, antimicrobial profiling of fungal endophytes from medicinal plant Adiantum philippense revealed bioactive Nigrospora sphaerica from the leaf segment. Chemical and biological profiling through TLC–bioautography and hyphenated spectroscopic techniques confirmed the presence of phomalactone as an antimicrobial metabolite.
Results
The chemical investigation of the broth extract by bioassay-guided fractionation confirmed phomalactone as a bioactive antimicrobial secondary metabolite. The antimicrobial activity of phomalactone was found to be highest against Escherichia coli by disc diffusion assay. The MIC was found to be significant against both Escherichia coli and Xanthomonas campestris in the case of bacteria and dermatophyte Candida albicans at 150 μg/ml, respectively.
Conclusions
Overall, the results highlighted the antimicrobial potential of phomalactone from the endophyte Nigrospora sphaerica exhibiting a broad spectrum of antimicrobial activity against human and phytopathogenic bacteria and fungi. This work is the first report regarding the antibacterial activity of phomalactone.
Keywords: Adiantum philippense, Nigrospora sphaerica, Phomalactone, Antimicrobial activity, TLC-bioautography
Background
Endophytes such as bacteria, fungi, and actinomycetes inhabit healthy plant tissues and have a crucial role in the defense mechanism of the host against pathogens, herbivores, and abiotic stresses [27, 35]. Until the previous decade, research on endophytic microbes was confined only to diversity and distribution. However, a new avenue was envisioned because of taxol from Taxomyces andreanae inhabiting Taxus brevifolia [18, 26].
Natural products from endophytes have gained wide attention from the research community due to their wide structural diversities with potential biological applications. However, the quest for chemical diversity attributed to secondary metabolites from endophytes has been led to an increased number of redundancies; making it laborious for natural product researchers for confining new analogs with potent biological activities [16, 24].
The genus Nigrospora has been reported previously to produce bioactives viz., nigrosporolides, phomalactone [8, 10], nigrosporins [17], lactones, epoxydons [29], diterpenes, diketopiperazines, lactones [25], nigrosporolides, and pyrones. The plant source Adiantum philippense L. is commonly known as “Hanspadi” or '”Strolling Maidenhair plant.” A. philippense has been traditionally used numerous parts of India as an ethnomedicinal as well as the cosmetic plant [21]. The ethnomedicinal aspects include the treatment of illnesses, consuming sensation, erysipelas, epileptic fits, looseness of the bowels, bronchitis, coughing, and elephantiasis [2]. Earlier reports have stated the potential capacity of the plant exhibiting antibacterial and antifungal activities.
The present investigation emphasizes the identification of endophytic fungus N. sphaerica inhabiting A. philippense, and bioactivity-guided dereplication process led to the isolation of a potent antimicrobial agent phomalactone. To the best of our knowledge, this is the first report elaborating the antibacterial activity of phomalactone.
Methods
Materials
Potato dextrose agar (PDA) and broth (PDB), Mueller-Hinton agar (MHA) and broth (MHB), Sabouraud dextrose agar (SDA), gentamicin, nystatin, and sodium dodecyl sulfate (SDS) were purchased from HiMedia (Mumbai, India). Other materials were obtained from different manufacturers such as sodium hypochlorite solution (available chlorine 4%) from Fisher Scientific (Mumbai, India); Precoated aluminum-backed TLC silica gel plates (60 F254) from Merck (Darmstadt, Germany); HPLC grade solvents like ethyl acetate; hexane and methanol from SDFCL (Mumbai, India); and Silica gel 60–120 mesh from Qualigens (Mumbai, India). The ITS 1 and ITS 4 primers, 2,3,5-triphenyl tetrazolium chloride (TTC), and Thiazolyl Blue Tetrazolium Bromide (MTT) were procured from Sigma-Aldrich (Missouri, USA).
Test organisms
All the test microbial pathogens such as Staphylococcus aureus (MTCC 7443), Bacillus subtilis (MTCC 121), Bacillus cereus (MTCC 430), Staphylococcus epidermidis (MTCC 435), Escherichia coli (MTCC 7410), Klebsiella pneumonia (MTCC 7407), Salmonella typhi (MTCC 733), Shigella flexneri (MTCC 1457), Vibrio parahaemolyticus ((MTCC 451), Xanthomonas campestris (MTCC 7908), and Candida albicans (MTCC 183) were procured from Microbial Type Culture Collection and Gene Bank (MTCC; Chandigarh, India).
Plant collection and isolation of fungal endophytes
Healthy asymptomatic A. philippense was collected from the Western Ghats region near Virajpete (12.2° N, 75.8° E). The plant specimen was identified by Dr. S. Mahadevakumar (field taxonomist) and submitted to herbarium (Voucher specimen number: UOM-BOT20-AP02). The plant material was sealed in sterile polythene bags and transported to the lab and processed within 8 h of collection. The plant material was initially washed under tap water for removing unwanted debris and soil; followed by sterile double distilled water (Dw) washes for twice. The plant leaf material was separated and cut into segments of 0.5 cm2 size. The plant segments were subjected to surface sterilization with 75% (v/v) ethanol (1 min), followed by 4% (v/v) NaOCl (4 min) and 75% (v/v) ethanol (1 min). Finally, tissue bits were rinsed with sterile double distilled water to remove residual surface sterilizing agents and blot dried under aseptic conditions. The surface-sterilized and blot dried leaf segments were placed on potato dextrose agar amended with antibiotic chloramphenicol (100 mg/L) to eliminate bacterial growth followed by incubation in a light chamber for two weeks at a 12-h light/dark cycles at 25 ± 2 °C. The fungal colonies were picked and transferred onto fresh potato dextrose agar plates devoid of any antibiotics [15, 23].
Genomic DNA extraction
Bioactive mycoendophyte N. sphaerica isolated from A. philippense was cultured in potato dextrose broth for a week at 25 ± 2 °C for isolation of genomic DNA. The mycelial mat was harvested, grounded, and transferred to a microcentrifuge tube containing 1 ml of 2× CTAB extraction buffer and incubated at 65 °C water bath for 30 min, later centrifuged at 10,000 g (10 min; RT). The aqueous phase was mixed with equal volume phenol: chloroform: isoamyl alcohol (25:24:1) for total DNA extraction followed by the addition of propanol to precipitate DNA [9].
Polymerase chain reaction amplification
The PCR amplification was performed according to the protocol of White et al. [31] using ITS1 and ITS4 set of universal primers. The PCR reaction mixture (50 μL) was prepared with 5 μL PCR buffer (10X; 15 mM MgCl2), 5 μL of dNTPs (2 mM), 2 μL of forward and reverse primers (5 pmole/μL), 2 μL Taq polymerase (1 U/μL), and the final volume was made up for 50 μL using Nanopure water (30 μL). The PCR reaction was carried out for 30 cycles with the following conditions denaturation 94 °C (40 s), annealing at 54 °C (60 s), extension at 72 °C (60 s), and final extension for a 10-min interval at 72 °C. The sequence was analyzed using ABI 3730 sequencer.
Antimicrobial screening by agar plug method
The pure cultures of fungal endophytes isolated from A. philippense were preliminarily screened for antimicrobial activity using the agar plug diffusion method. Pure cultures of fungal endophytes were cultured in potato dextrose agar for 21 days at 25 ± 2 °C. The agar plugs of pure cultures were placed onto Mueller-Hinton agar preseeded with test organisms, followed by refrigeration at 4 °C for 1 h to facilitate diffusion of metabolites, and further plates were incubated at 37 ± 2 °C (24 h) for bacteria and 25 ± 2 °C (72 h) for fungi. After incubation, zones of inhibition around the agar plug were observed [37].
Fermentation and extraction of secondary metabolites
Bioactive N. sphaerica was cultured in 2 L Erlenmeyer flasks (10) containing 450 ml potato dextrose broth at 25 ± 2 °C for 4 weeks under static conditions. The culture broth was filtered, and the liquid supernatant was extracted thrice with an equal volume of ethyl acetate and concentrated using a rotary flash evaporator (Rotavapor R® R-3, Buchi) (50 °C) and it was stored at 4 °C. The ethyl acetate extract concentrate was fractionated by column chromatography over a silica gel column (50 g, 60–120 mesh) using stepwise gradient elution from hexane: ethyl acetate (100:0 to 0:100) mixtures with increasing polarity, to afford different fractions (eluates). The fractions obtained were developed in TLC for pooling the similar fractions using optimized solvent system ethyl acetate: hexane (1:1; v/v) [22].
Detection of antimicrobial metabolite by TLC-bioautographic assay
Analytical TLC was employed for detecting antimicrobial metabolites. Ten microliters of flash evaporated ethyl acetate fraction of bioactive mycoendophyte N. sphaerica was spotted on TLC silica gel plates and developed in an optimized solvent system of ethyl acetate/hexane (1:1; v/v). TLC sheets were observed under UV light (254 nm) and dried in aseptic conditions. The developed TLC sheets were placed onto sterile Petri plates and overlaid with Mueller-Hinton agar amended with TTC (1 mg/ml) for bacteria and Sabouraud Dextrose agar for fungi previously seeded with 1% standardized (McFarland standard) microbial inoculum and incubated. After incubation, for fungi, the Petri plate was flooded with 10 ml of soft agar (agar 1% w/v) amended with MTT (0.05% w/v). Inhibition zones were observed as clear spots, and the active bands and corresponding retention factor (Rf) value was measured [19, 23].
Antimicrobial activity by disc diffusion method
The disc diffusion method was used to determine the antimicrobial activity of the endophytic fungal extract. Sterile media plates (MHA for bacteria and SDA for fungi) were seeded with predetermined test microbial inocula as described by Rakshith et al. [22]. Sterile discs were impregnated with purified bioactive metabolites from the stock solution (10 mg/ml). The concentration of 30, 60, 150, 300, 450, and 600 μgdisc-1 were placed on respective agar media with gentamicin (10 μg/disc; for bacteria) and nystatin (100 U/disc; for fungi) as a positive control, whereas ethyl acetate served as a negative control. Inoculated plates were incubated at 37 ± 2 °C (24 h) for bacteria and 25 °C ± 2 (72 h) fungi. After the incubation, the zone of inhibition was measured around discs in millimeter and results were expressed as mean ± SD.
Spectral measurements
HPLC profiling
The purity of the bioactive metabolite was analyzed with reference to the chromatogram of the crude ethyl acetate extract of N. sphaerica with Shimadzu UFLC – LC – 20 AD series. An amenable 5 μm C18 120 Å, 250 × 4.6 mm LC (A8-ST5C18G120-98) column was used for the detection of metabolites. The injection volume of 20 μL (1 mg/ml) was developed with the mobile phase using methanol with a flow rate of 1 ml/min. The chromatogram was recorded at 260 nm using Lab solutions (Shimadzu corp., Japan) software.
LC-MS
The mass of the purified bioactive metabolite was measured using liquid chromatography coupled with Q-TOF in positive electrospray ionization-mass spectrometry (Waters Acquity UPLC Synapt G2 HDMS) with BDS HYPERSIL C18 column (250 × 4.6 mm × 5 μm). The LC separation was recorded using Quattro Premier XE with the Mass Lynx 4.1 software with a gradient solvent system A: 0.1 vol. % formic acid–water and B: 0.1 vol. % formic acid–acetonitrile; 2–98 % B in 50.0 min of run time with a controlled column temperature at 30 °C. The Q-TOF–ESI–MS data were recorded in the range of 200 and 400 nm and positive ESI full MS (60.00–1000.00).
NMR
The 1H and 13C NMR spectra of the purified bioactive metabolite (35 mg/ml) were recorded using deuterated chloroform (d-CDCl3) on an Agilent 400-MHz WB (Widerbore) NMR magnet (Santa Clara CA, USA) spectrometer using the VJ3.1 software at 400 MHz and 100 MHz, respectively.
FT-IR
Fourier transform infrared spectra of the bioactive purified fraction (1 μLof 1 mg/ml) was recorded using PerkinElmer spectrum TwoTM ATR MIRacle Diamond S2PE (Norwalk, CT, USA) spectrophotometer with the scanning range of 4000–600 cm-1.
Determination of minimal inhibitory concentration
The MIC was determined by the microdilution method according to Clinical and Laboratory Standards Institute (CLSI) by modifications by [23]. Briefly, the stock solutions of purified phomalactone (10 mg/ml), Gentamicin, and Nystatin (2 mg/ml) were prepared. Two-fold dilutions were carried out in the concentration range of 100–0.19 μg/ml, in 100 μL of sterile Mueller Hinton broth for bacteria and Sabouraud’s dextrose broth for fungi. Twenty microliters of standard suspension of bacterial and fungal inocula were added, except for sterility control well. Gentamicin for bacteria and Nystatin for fungi used as a standard positive control along with growth and sterility controls. Minimal inhibitory concentrations were determined by absorbance at 600 nm after incubation with compounds at 37 ± 2 °C (24 h) for bacteria and 25 °C ± 2 (72 h) fungi [15].
Statistical analysis
All the experiments were conducted in triplicates and statistical significance such as one-way ANOVA was evaluated using IBM SPSS (Version 25) software.
Results
Isolation and identification of endophytic fungi Nigrospora sphaerica
In the present study, bioactive mycoendophyte isolated from the surface-sterilized leaves of A. philippense was subjected to morphological, microscopic (Fig. 1), and molecular identification. Based on ITS rDNA gene sequencing, it was identified as N. sphaerica and submitted to GenBank (Accession number: MF400860).
Fig. 1.
Plant specimen, morphology, and microscopy of Nigrospora sphaerica
Phylogenetic affiliation
The amplified sequenced results were processed using Mega X software for assigning putative identity and for assigning OTU’s based similarity. Followed by a neighbor-joining algorithm with a bootstrap value of 1000 for assigning phylogenetic affiliation (Fig. 2).
Fig. 2.
Phylogenetic tree derived from neighbor-joining analysis showing the evolutionary relationship using the MEGA-X software
Antimicrobial activity of ethyl acetate extract N. sphaerica
The antimicrobial activity of phomalactone from N. sphaerica was determined by the disc diffusion assay against a panel of test pathogenic microorganisms. The bioactive compound exhibited an excellent zone of inhibition against all the test microbial pathogens in an increasing order. The antimicrobial activity was found to be highest against E. coli with a 24.33 mm diameter followed S. typhi (22.67 mm), B. cereus (21.67 mm), S. aureus (19 mm), K. pneumonia (18.67 mm), B. subtilis (17.67 mm), X. campestris (17.67 mm), V. parahaemolyticus (16.67 mm), and S. epidermidis (12.67 mm) at 30 μgdisc-1 concentration. The metabolite was effective against Candida albicans at a higher concentration of 150 μg (Fig. 3, Table 1).
Fig. 3.
Antimicrobial activity of phomalactone isolated from N. sphaerica. NOTE: Standard gentamicin (10 μg disc-1; for bacteria) and nystatin (100 U disc-1; for fungus) (S), negative control (1), 30 μg disc-1 (2), 60 μg disc-1 (3), 150 μg disc-1 (4), 300 μg disc-1 (5), 450 μg disc-1 (6), and 600 μg disc-1 (7)
Table 1.
Antimicrobial activity of phomalactone
| Sl. no. | Test organism | Disc diffusion assay | MIC (in μg) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gentamicin (10 μg disc-1) |
30 μg disc-1 | 60 μg disc-1 | 150 μg disc-1 | 300 μg disc-1 | 450 μg disc-1 | 600 μg disc-1 | Phomalactone | Gentamicin | ||
| 1. | Bacillus cereus | 19.33 ± 0.58f | 21.67 ± 0.58e | 23.33 ± 0.58d | 25.33 ± 0.58c | 26.67 ± 0.58bc | 28.00 ± 0.00ab | 29.33 ± 0.58a | 6.25 | 0.78 |
| 2. | Bacillus subtilis | 20.33 ± 0.58de | 17.67 ± 0.58f | 19.33 ± 0.58ef | 21.67 ± 0.58cd | 23.33 ± 0.58c | 26.33 ± 0.58b | 31.00 ± 1.00a | 6.25 | 0.19 |
| 3. | Escherichia coli | 20.33 ± 0.58f | 24.33 ± 0.58e | 25.00 ± 0.00de | 26.33 ± 0.58cd | 27.33 ± 0.58bc | 29.00 ± 1.00b | 31.67 ± 0.58a | 3.12 | 0.39 |
| 4. | Klebsiella pneumonia | 21.33 ± 0.58d | 18.67 ± 0.58e | 21.33 ± 0.58d | 22.67 ± 0.58d | 25.67 ± 0.58d | 27.33 ± 0.58b | 29.33 ± 0.58a | 6.25 | 1.56 |
| 5. | Salmonella typhi | 21.00 ± 1.00f | 22.67 ± 0.58ef | 23.67 ± 0.58de | 25.00 ± 0.00cd | 26.33 ± 0.58bc | 27.67 ± 0.58b | 30.00 ± 1.00a | 6.25 | 0.39 |
| 6. | Shigella flexneri | 19.67 ± 0.58f | 20.33 ± 0.58ef | 22.00 ± 1.00de | 23.67 ± 0.58cd | 25.67 ± 0.58c | 28.00 ± 1.00b | 31.00 ± 1.00a | 6.25 | 1.56 |
| 7. | Staphylococcus aureus | 26.33 ± 0.58bc | 19.00 ± 1.00e | 21.67 ± 0.58d | 24.67 ± 0.58c | 26.00 ± 0.00bc | 27.33 ± 0.58b | 31.00 ± 1.00a | 12.5 | 0.19 |
| 8. | Staphylococcus epidermidis | 27.67 ± 0.58a | 12.67 ± 0.58d | 17.67 ± 0.58c | 22.67 ± 0.58b | 24.67 ± 0.58b | 27.00 ± 1.00a | 29.00 ± 1.00a | 12.5 | 0.19 |
| 9. | Vibrio parahaemolyticus | 17.33 ± 0.58de | 16.67 ± 0.58e | 18.67 ± 0.58d | 22.33 ± 0.58c | 24.33 ± 0.58b | 25.67 ± 0.58ab | 26.67 ± 0.58a | 6.25 | 0.78 |
| 10. | Xanthomonas campestris | 30.00 ± 1.00b | 17.67 ± 0.58e | 19.33 ± 0.58e | 22.00 ± 1.00d | 24.67 ± 0.58c | 31.00 ± 1.00b | 33.67 ± 0.58a | 3.12 | 0.39 |
| 11 | Candida albicans | 25.67 ± 0.58a | NA | NA | 16.33 ± 0.58d | 17.33 ± 1.15cd | 18.67 ± 0.58bc | 20.33 ± 0.58b | 12.5 | 0.19 |
Values followed by the same superscript letter(s) are significantly different at (p < 0.05) by Tukey’s post hoc test
NA no activity
TLC-bioautography assay
Metabolite with antimicrobial activity was identified as a clear zone against a red background on Mueller-Hinton agar plates and a dark blue background on the Sabouraud Dextrose agar plate. The zone of inhibition was observed at a Rf = 4.5 indicating the purified bioactive metabolite from the ethyl acetate extract of N. sphaerica (Fig. 4).
Fig. 4.
TLC bioautography assay of purified phomalactone against selected microbial pathogens. (1) S. typhi, (2) E. coli, (3) S. aureus, (4) C. albicans, (5) TLC chromatogram (under UV light), and (6) structure of phomalactone
Spectral data
Color: Yellow
Physical state: Amorphous Semi-Solid
Yield: 0.45 g/L
Name: Phomalactone [(5R, 6R)-5 hydroxy-6-[(E)-prop-1-en-1-yl]-5, 6-dihydroxy-2 h-pyran-2-one].
HPLC: The purified compound eluted at RT-4.89 with 86% purity (Supplementary Figure 1).
LCMS: 155.126 (positive mode) (Supplementary Figure 2)
NMR:
1H NMR: (400 MHz, CDCl3-d6, ℧, ppm): 2.05 (s, 3H), 2.80 (s, 1H, –OH), 4.53 (m, 1H), 4.76 (m, 1H) 5.67–5.69 (dd, or q, 2H), 6.03–6.04 (m, 2H) (Supplementary Figure 3).
13C NMR: (100 MHz, CDCl3-d6, ℧, ppm): 17.6 (C-9), 63.8 (C-5), 122.3 (C-3), 132.7 (C-8), 144.8 (C-4), 162.1 (C-2, C-0), 83.3 (C-6), 123.5 (C-7). MS (ESI, m/z): 154.06, (100%), 155.07 (M + 1) (Supplementary Figure 4).
FT-IR: 3600-3200 (S, –OH stretch), 1750–1720 (ether), 1680–1600 (alkene), 1448 (CH3-bond), 1050–1150 (> C=O (1160) stretch), 1380 (–CH-bond) (Supplementary Figure 5).
The compound obtained was in the form of a yellow amorphous semi-solid with a molecular mass of 155.07 in ESI-positive mode. The 1H NMR spectrum revealed the presence of a secondary methyl group attached to carbon 5 in the compound. The 13C NMR revealed 8 carbon signals: signals for one quaternary carbon atoms, 6 methane groups, and one methyl group representing dihydropyranon chemical skeleton. The presence of the hydroxyl group at 3600–3200 cm-1 and carbonyl at 1160 cm-1 confirmed the bioactive to be phomalactone.
Minimal inhibitory concentration
The MIC was found to be lowest against E. coli and X. campestris at 3.12 μg concentration followed by S. typhi, B. subtilis, B. cereus, and K. pneumonia at 6.25 μg. The inhibition was observed at 12.5 μg for S. aureus, S. epidermidis, and C. albicans (Table 1). The results obtained indicated that Gram-negative bacteria were found to be more susceptible when compared to Gram-positive.
Discussions
Nigrospora sphaerica has also been reported from a vast range of host viz., Ginkgo biloba [20], Moringa oleifera [38], Phoenix dactylifera [1] and Saccharum arundinaceum [36]. In this study, the secondary metabolites of N. sphaerica, extracted with ethyl acetate showed a significant antimicrobial activity against bacteria and fungus viz., S. aureus, B. subtilis, S. epidermidis, E. coli, K. pneumonia, P. aeruginosa, S. typhi, S. flexneri, X. campestris, V. parahaemolyticus, and C. albicans, respectively. Several bioactive compounds have been reported from N. sphaerica which suggests the potential for discovery of pharmaceutically relevant substances. Previously, it was reported N. sphaerica to produce new antimicrobial bioactive secondary metabolites, such as nigrosporolides [5], nigrosporins [28], lactones [4], epoxydons and pyrones, diterpenes, diketopiperazines [3], and nigrosporolides [37].
Phomalactone is quite insecticidal [14] and has been isolated previously from several species of the fungal genera Nigrospora [30, 33], Xylaria [6], Aspergillus [11], Verticillium [7], Drechslera [13], Hirsutella (entomopathogenic) [12], Paecilomyces (entomopathogenic) [32], and Phoma [34]. Phomalactone has antifungal activity against Aspergillus fumigatus [11], nematocidal activity [7], immunomodulating activity [13], insecticide activity [12], and phytotoxic activity [4].
Phomalactone from endophyte Xylaria sp. exhibited to possess weak activity at 13 μg/ml against protozoan Plasmodium falciparum was reported by Carlos et al. 2008. A study conducted by Kumudini et al. 2015 reported phomalactone from N. sphaerica had larvicidal, adulticide activity against Aedes aegypti and Anopheles quadrimaculatus mosquitoes with LD50 value 0.64 μg/org and 0.20 μg/org, respectively. The investigation of biopotential endophytes inhabiting Zoysia japonica Steud by Kim et al. 2001 revealed phomalactone isolated from N. sphaerica exhibited potent fungitoxic activity against Phytophthora infestans and Phytophthora capsici. Its ecological role(s) in each of these species has not been rigorously studied, but its phytotoxic, fungitoxic, and insecticidal activities may be important to the various fungi that produce phomalactone.
Conclusion
In conclusion, this is the first report on the isolation of N. sphaerica from medicinal plant A. philippense. Chemical investigation through bioautography N. sphaerica displayed a broad spectrum of antimicrobial activity, which indicated that endophytic N. sphaerica as a potent producer of bioactive phomalactone derivative with great potential as a natural product drug molecule.
Supplementary information
Additional file 1: Supplementary Figure 1. HPLC analysis of purified bioactive compound phomalactone.
Additional file 2: Supplementary Figure 2. LCMS spectra of purified bioactive compound phomalactone.
Additional file 3: Supplementary Figure 3. Proton (1H) NMR Spectra of purified bioactive compound phomalactone.
Additional file 4: Supplementary Figure 4. 13C NMR Spectra of purified bioactive compound phomalactone.
Additional file 5: Supplementary Figure 5. FT-IR Spectra of purified bioactive compound phomalactone.
Acknowledgements
The first author Ramesha K. P would like to thank UGC for providing Senior Research Fellowship, University Grants Commission Fellowship ID 201516-RGNF-2015-17-SC-KAR-17538. The author Chandra Mohana. N would like to thank ICMR, New Delhi, for providing senior research fellowship (ICMR-SRF award No: 45/69/2018-PHA/BMS/OL). The author Nuthan B.R. would like to thank ICMR, New Delhi, for providing senior research fellowship (ICMR SRF Award No: OMI-Fellowship/23/2018-ECD-1). The authors are very thankful to the Institution of Excellence (IOE), University of Mysore; Department of Studies in Microbiology, University of Mysore, and Indian Institute of Science, Bengaluru, India, for providing instrumentation facilities.
Abbreviations
- Dw
Distilled water
- PDA
Potato dextrose agar
- PDB
Potato dextrose broth
- MHA
Mueller-Hinton Agar
- TLC
Thin layer chromatography
- TTC
2,3,5-Triphenyltetrazolium chloride
- MTT
1-(4,5-Dimethylthiazol-2-yl)-3,5-diphenylformazan, Thiazolyl blue formazan
- SDA
Sabouraud dextrose agar
- MIC
Minimal inhibitory concentration
Authors’ contributions
RKP and SS designed the concept and prepared the manuscript; RKP executed the experiments and data analysis; NCM assisted in the experiment, data analysis, preparation of manuscript along with proof correction; and NBR and RD helped in proof correction. The authors have read and approved the manuscript.
Funding
Not applicable.
Availability of data and materials
The data from the study is publicly available.
Ethics approval and consent to participate
Not applicable.
Consent for publication
All the authors approve the manuscript for publication.
Competing interests
The authors declare there is no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Kolathuru Puttamadaiah Ramesha, Email: rameshdasarath@gmail.com.
Nagabhushana Chandra Mohana, Email: chandra.mohanachar@gmail.com.
Bettadapura Rameshgowda Nuthan, Email: nuthanram3@gmail.com.
Devaraju Rakshith, Email: rakshithdevraj@yahoo.co.in.
Sreedharamurthy Satish, Email: satish.micro@gmail.com.
Supplementary information
Supplementary information accompanies this paper at 10.1186/s43141-020-00080-4.
References
- 1.Abass MH, Hameed MA, Ahmed AN. First report of Nigrospora sphaerica (Sacc.) Mason as a potential pathogen on date palm (Phoenix dactylifera L.) Can J Plant Pathol. 2013;35(1):75–80. doi: 10.1080/07060661.2012.732612. [DOI] [Google Scholar]
- 2.Ali MS, Amin MR, Kamal CMI, Hossain MA. In vitro antioxidant, cytotoxic, thrombolytic activities and phytochemical evaluation of methanol extract of the A. philippense L. leaves. Asian Pac J Trop Biomed. 2013;3(6):464–469. doi: 10.1016/S2221-1691(13)60097-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Cutler HG, Hoogsteen K, Littrell RH, Arison BH. Epoxyexserohilone, a novel metabolite from Nigrospora sphaerica. Agric Biol Chem. 1991;55(8):2037–2042. [Google Scholar]
- 4.Fukushima T, Tanaka M, Gohbara M, Fujimori T. Phytotoxicity of three lactones from Nigrospora sacchari. Phytochemistry. 1998;48(4):625–630. doi: 10.1016/S0031-9422(97)01023-6. [DOI] [Google Scholar]
- 5.Harwooda JS, Cutler HG, Jacyno JM. Nigrosporolide, a plant growth-inhibiting macrolide from the mould Nigrospora sphaerica. Nat Prod Lett. 1995;6(3):181–185. doi: 10.1080/10575639508043156. [DOI] [Google Scholar]
- 6.Jiménez-Romero C, Ortega-Barría E, Arnold AE, Cubilla-Rios L. Activity against Plasmodium falciparum of lactones isolated from the endophytic fungus Xylaria sp. Pharm Biol. 2008;46(10-11):700–703. doi: 10.1080/13880200802215859. [DOI] [Google Scholar]
- 7.Khambay BPS, Bourne JM, Cameron S, Kerry BR, Zaki MJ. A nematicidal metabolite from Verticillium chlamydosporium. Pest Manag Sci. 2000;56(12):1098–1099. doi: 10.1002/1526-4998(200012)56:12<1098::AID-PS244>3.0.CO;2-H. [DOI] [Google Scholar]
- 8.Kim JC, Choi GJ, Park JH, Kim HT, Cho KY. Activity against plant pathogenic fungi of phomalactone isolated from Nigrospora sphaerica. Pest Manag Sci. 2001;57(6):554–559. doi: 10.1002/ps.318. [DOI] [PubMed] [Google Scholar]
- 9.Kim JS, Jun BK, Kim SH. Simple and reliable DNA extraction method for the dark pigmented fungus, Cercospora sojina. Plant Pathol J. 2010;26(3):289–292. doi: 10.5423/PPJ.2010.26.3.289. [DOI] [Google Scholar]
- 10.Kim J-C, Choi GJ, Park J-H, Kim HT, Cho KY. Activity against plant pathogenic fungi of phomalactone isolated from Nigrospora sphaerica. Pest Manag Sci. 2001;57(6):554–559. doi: 10.1002/ps.318. [DOI] [PubMed] [Google Scholar]
- 11.Komai SI, Hosoe T, Nozawa K, Okada K, De Campos Takaki GM, Fukushima K, Miyaji M, Horie Y, Kawai KI. Antifungal activity of pyranone and furanone derivatives, isolated from Aspergillus sp. IFM51759, against Aspergillus fumigatus. Mycotoxins. 2003;53:11–17. doi: 10.2520/myco.53.11. [DOI] [Google Scholar]
- 12.Krasnoff SB, Gupta S. Identification of the antibiotic phomalactone from the entomopathogenic fungus Hirsutella thompsonii var. synnematosa. J Chem Ecol. 1994;20(2):293–302. doi: 10.1007/BF02064437. [DOI] [PubMed] [Google Scholar]
- 13.Krivobok S, Thomasson F, Seigle-Murandi F, Steiman R, Bottex-Gauthier C. 6-Allyl-5,6-dihydro-5-hydroxypyran-2-one, a lactone produced by a new Drechslera species: specified 1H and 13C NMR assignments, mutagenic and immunomodulating testings. Pharmazie. 1994;49:605–607. [PubMed] [Google Scholar]
- 14.Meepagala KM, Becnel JJ, Estep AS. Phomalactone as the active constituent against mosquitoes from Nigrospora spherica. Agric Sci. 2015;6(10):1195. [Google Scholar]
- 15.Mohana NC, Rao HCY, Rakshith D, Nuthan BR, Ramesha KP, Satish S (2020) Bioassay guided fractionation of bioactive metabolite from Corynascus verrucosus inhabiting Croton bonplandianus Baill. Process Biochem
- 16.Mohana NC, Rao HY, Rakshith D, Mithun PR, Nuthan BR, Satish S. Omics based approach for biodiscovery of microbial natural products in antibiotic resistance era. J Genetic Eng Biotechnol. 2018;16(1):1–8. doi: 10.1016/j.jgeb.2018.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Murakami A (1970) NII-electronic library service. Chem Pharm Bull 2091
- 18.Naik S, Shaanker RU, Ravikanth G, Dayanandan S. How and why do endophytes produce plant secondary metabolites? Symbiosis. 2019;78(3):193–201. doi: 10.1007/s13199-019-00614-6. [DOI] [Google Scholar]
- 19.Nuthan BR, Rakshith D, Marulasiddaswamy KM, Rao HCY, Ramesha KP, Mohana NC et al (2020) Application of optimized and validated agar overlay TLC–bioautography assay for detecting the antimicrobial metabolites of pharmaceutical interest. J Chromatogr Sci:1–10. 10.1093/chromsci/bmaa045 [DOI] [PubMed]
- 20.Pawle G, Singh SK. Antimicrobial, antioxidant activity and phytochemical analysis of an endophytic species of Nigrospora isolated from living fossil Ginkgo biloba. Curr Res Environ Appl Mycol. 2014;4(1):1–9. doi: 10.5943/cream/4/1/1. [DOI] [Google Scholar]
- 21.Périco LL, Rodrigues VP, de Almeida LFR, Fortuna-Perez AP, Vilegas W, Hiruma-Lima CA. Medicinal and aromatic plants of South America. Dordrecht: Springer; 2018. Maytenus ilicifolia Mart. Ex Reissek; pp. 323–335. [Google Scholar]
- 22.Rakshith D, Gurudatt DM, Rao HCY, Mohana NC, Nuthan BR, Ramesha KP, Satish S. Bioactivity-guided isolation of antimicrobial metabolite from Xylaria sp. Process Biochem. 2020;92:378–385. doi: 10.1016/j.procbio.2020.01.028. [DOI] [Google Scholar]
- 23.Rakshith D, Santosh P, Tarman K, Gurudatt D, Satish S. Dereplication strategy for antimicrobial metabolite using thin-layer chromatography-bioautography and LC-PDA-MS analysis. JPC J Planar Chromatograph Modern TLC. 2013;26(6):470–474. doi: 10.1556/JPC.26.2013.6.2. [DOI] [Google Scholar]
- 24.Ramesha KP, Mohana NC, Nuthan BR, Rakshith D, Satish S. Epigenetic modulations of mycoendophytes for novel bioactive molecules. Biocatalysis Agricultural Biotechnol. 2018;16:663–668. doi: 10.1016/j.bcab.2018.09.025. [DOI] [Google Scholar]
- 25.Rukachaisirikul V, Khamthong N, Sukpondma Y, Phongpaichit S, Hutadilok-Towatana N, Graidist P, Kirtikara K. Cyclohexene, diketopiperazine, lactone and phenol derivatives from the sea fan-derived fungi Nigrospora sp. PSU-F11 and PSU-F12. Arch Pharm Res. 2010;33(3):375–380. doi: 10.1007/s12272-010-0305-3. [DOI] [PubMed] [Google Scholar]
- 26.Strobel G, Daisy B. Bioprospecting for microbial endophytes and their natural products. Microbiol Mol Biol Rev. 2003;67(4):491–502. doi: 10.1128/MMBR.67.4.491-502.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Suryanarayanan TS, Thirunavukkarasu N, Govindarajulu MB, Sasse F, Jansen R, Murali TS. Fungal endophytes and bioprospecting. Fungal Biol Rev. 2009;23(1-2):9–19. doi: 10.1016/j.fbr.2009.07.001. [DOI] [Google Scholar]
- 28.Tanaka M, Fukushima T, Tsujino Y, Fujimori T. Nigrosporins a and B, new phytotoxic and antibacterial metabolites produced by a fungus Nigrospora oryzae. Biosci Biotechnol Biochem. 1997;61(11):1848–1852. doi: 10.1271/bbb.61.1848. [DOI] [PubMed] [Google Scholar]
- 29.Trisuwan K, Rukachaisirikul V, Sukpondma Y, Preedanon S, Phongpaichit S, Rungjindamai N, Sakayaroj J. Epoxydons and a pyrone from the marine-derived fungus Nigrospora sp. PSU-F5. J Nat Prod. 2008;71(8):1323–1326. doi: 10.1021/np8002595. [DOI] [PubMed] [Google Scholar]
- 30.Trisuwan K, Rukachaisirikul V, Sukpondma Y, Preedanon S, Phongpaichit S, Sakayaroj J. Pyrone derivatives from the marine-derived fungus Nigrospora sp. PSU-F18. Phytochemistry. 2009;70(4):554–557. doi: 10.1016/j.phytochem.2009.01.008. [DOI] [PubMed] [Google Scholar]
- 31.White TJ, Bruns T, Lee S, Taylor JW. In: Amplification and direct sequencing of fungal genes for phylogeneticsin PCR protocols: a guide to methods and applications. Innis M, Gelfand DH, Sninsky JJ, White TJ, editors. San Diego: Academic Press; 1990. pp. 315–322. [Google Scholar]
- 32.Wu HY, Wang YL, Tan JL, Zhu CY, Li DX, Huang R, Niu XM. Regulation of the growth of cotton bollworms by metabolites from an entomopathogenic fungus Paecilomyces cateniobliquus. J Agric Food Chem. 2012;60(22):5604–5608. doi: 10.1021/jf302054b. [DOI] [PubMed] [Google Scholar]
- 33.Wu SH, Chen YW, Shao SC, Wang LD, Yu Y, Li ZY, Huang R. Two new solanapyrone analogues from the endophytic fungus Nigrospora sp. YB-141 of Azadirachta indica. Chem Biodivers. 2009;6(1):79–85. doi: 10.1002/cbdv.200700421. [DOI] [PubMed] [Google Scholar]
- 34.Yamamoto I, Suide H, Hemmi T, Yamano T. Antimicrobial α, β-unsaturated δ-lactones from molds. Takeda Kenkyusho Ho. 1970;29(1):1–10. [Google Scholar]
- 35.Zhang HW, Song YC, Tan RX. Biology and chemistry of endophytes. Nat Prod Rep. 2006;23(5):753–771. doi: 10.1039/b609472b. [DOI] [PubMed] [Google Scholar]
- 36.Zhang H, Deng Z, Guo Z, Tu X, Wang J, Zou K. Pestalafuranones F–J, five new furanone analogues from the endophytic fungus Nigrospora sp. BM-2. Molecules. 2014;19(1):819–825. doi: 10.3390/molecules19010819. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Zhang Y, Mu J, Feng Y, Kang Y, Zhang J, Gu PJ, Zhu YH. Broad-spectrum antimicrobial epiphytic and endophytic fungi from marine organisms: isolation, bioassay and taxonomy. Marine Drugs. 2009;7(2):97–112. doi: 10.3390/md7020097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Zhao JH, Zhang YL, Wang LW, Wang JY, Zhang CL. Bioactive secondary metabolites from Nigrospora sp. LLGLM003, an endophytic fungus of the medicinal plant Moringa oleifera lam. World J Microbiol Biotechnol. 2012;28(5):2107–2112. doi: 10.1007/s11274-012-1015-4. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Additional file 1: Supplementary Figure 1. HPLC analysis of purified bioactive compound phomalactone.
Additional file 2: Supplementary Figure 2. LCMS spectra of purified bioactive compound phomalactone.
Additional file 3: Supplementary Figure 3. Proton (1H) NMR Spectra of purified bioactive compound phomalactone.
Additional file 4: Supplementary Figure 4. 13C NMR Spectra of purified bioactive compound phomalactone.
Additional file 5: Supplementary Figure 5. FT-IR Spectra of purified bioactive compound phomalactone.
Data Availability Statement
The data from the study is publicly available.




